Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin Lesions
NCT01735942 · Status: WITHDRAWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL
Last updated 2021-12-06
Summary
The purpose of this study is to find out the effectiveness of ingenol mebutate compared to cryotherapy (freezing of the tissue) for the treatment of face and scalp skin lesions.
Conditions
- Actinic Keratosis
Interventions
- DRUG
-
Ingenol mebutate
- PROCEDURE
-
cryotherapy
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Murad Alam, MD · Northwestern University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 89 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2016-05-31
- Completion
- 2016-05-31
More Related Trials
-
Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp
NCT01600014 ·Status: COMPLETED ·Phase: PHASE3
-
IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis
NCT02281682 ·Status: UNKNOWN ·Phase: PHASE4
-
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
NCT01541553 ·Status: COMPLETED ·Phase: PHASE3
-
The Real Life Topical Field Treatment of Actinic Keratosis Study
NCT02362152 ·Status: COMPLETED
-
Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks
NCT02090465 ·Status: COMPLETED
-
Efficacy and Safety of Cryotherapy Versus 5-Fluorouracil in the Treatment of Actinic Keratosis
NCT06461442 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
NCT01998984 ·Status: COMPLETED ·Phase: PHASE2
-
An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis
NCT03200912 ·Status: COMPLETED ·Phase: PHASE3
-
Ingenol Mebutate (Picato®) With Methyl Aminolevulinate Photodynamic Therapy for the Treatment of Actinic Keratosis
NCT02354391 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis
NCT02716714 ·Status: COMPLETED ·Phase: PHASE4
-
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
NCT00942604 ·Status: COMPLETED ·Phase: PHASE3
-
A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities
NCT01787383 ·Status: COMPLETED ·Phase: PHASE3
-
Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%
NCT01892137 ·Status: COMPLETED ·Phase: PHASE1
-
To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis
NCT02459795 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp
NCT02406014 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic Keratosis
NCT02242747 ·Status: COMPLETED ·Phase: NA
-
To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis
NCT02385318 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Actinic Keratoses (AK) on the Face
NCT02411851 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses
NCT00110682 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
NCT02654769 ·Status: COMPLETED ·Phase: PHASE3
-
TreatMent of ActInic KerAtosis Lesions : pharmacoepiDemiological Study of the Impact in Real Life of ingenOl Mebutate Gel (Picato®) on Patients Satisfaction
NCT04202445 ·Status: COMPLETED
-
Comparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis Treatment
NCT01459393 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
NCT00742391 ·Status: COMPLETED ·Phase: PHASE3
-
Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%
NCT01926496 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)
NCT00917306 ·Status: COMPLETED ·Phase: PHASE3